Disc Medicine (IRON) Other financing activities (2020 - 2026)
Disc Medicine's (IRON) quarterly Other financing activities came in at $1.0 million in Q1 2026, up 251.92% year-on-year from $287000.0 in Q1 2025, and up 213.61% on a QoQ basis from -$889000.0 in Q3 2025.
Disc Medicine (IRON) Other financing activities (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Other financing activities data on file, last reported at $1.0 million in Q1 2026.
- On a quarterly basis, Other financing activities rose 251.92% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 47.05% decrease from a year earlier, with the FY2025 full-year figure at $578000.0, down 80.58% from the prior year.
- Other financing activities for Q1 2026 stood at $1.0 million, up from -$889000.0 in the prior quarter.
- Over the last five years, Other financing activities for IRON reached as high as $1.9 million in Q3 2023 and fell as low as -$1.9 million in Q4 2023.
- Historically, Other financing activities has averaged $298937.5 across 5 years, with a median of $254500.0 in 2023.
- On a YoY basis, Other financing activities climbed as much as 8609.09% in 2023 and fell as far as 3521.43% in 2023.
- Year by year, Other financing activities stood at $56000.0 in 2022, then plunged by 3521.43% to -$1.9 million in 2023, then surged by 162.73% to $1.2 million in 2024, then slumped by 173.96% to -$889000.0 in 2025, then jumped by 213.61% to $1.0 million in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $1.0 million in Q1 2026, -$889000.0 in Q3 2025, and $1.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Sep 30, 2025 | -889,000.00 |
| Sep 30, 2025 | -889,000.00 |
| Jun 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 287,000.00 |
| Mar 31, 2025 | 287,000.00 |
| Dec 31, 2024 | 1.20 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 401,000.00 |
| Sep 30, 2024 | 401,000.00 |
| Jun 30, 2024 | 567,000.00 |
| Jun 30, 2024 | 567,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Dec 31, 2023 | -1.92 Mn |
| Dec 31, 2023 | -1.92 Mn |
| Sep 30, 2023 | 1.92 Mn |
| Sep 30, 2023 | 1.92 Mn |